Russell Investments Group, Ltd. - ASSERTIO THERAPEUTICS INC ownership

ASSERTIO THERAPEUTICS INC's ticker is ASRT and the CUSIP is 04545L107. A total of 1 filers reported holding ASSERTIO THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Russell Investments Group, Ltd. ownership history of ASSERTIO THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$600,000
-59.9%
914,283
-23.5%
0.00%
-33.3%
Q4 2019$1,498,000
+101.6%
1,194,895
+107.8%
0.00%
+200.0%
Q3 2019$743,000
-40.4%
574,912
+58.8%
0.00%
-50.0%
Q2 2019$1,247,000
+6.5%
362,061
+51.5%
0.00%0.0%
Q1 2019$1,171,000
+0.2%
238,939
-26.5%
0.00%
-33.3%
Q4 2018$1,169,000325,0490.00%
Other shareholders
ASSERTIO THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 3,278,000$11,834,0000.90%
Senvest Management, LLC 2,124,393$7,669,0000.66%
DELTEC ASSET MANAGEMENT LLC 351,176$1,268,0000.35%
PERKINS CAPITAL MANAGEMENT INC 99,600$360,0000.28%
Matarin Capital Management, LLC 838,619$3,027,415,0000.24%
GLOBEFLEX CAPITAL L P 196,357$709,0000.17%
Opaleye Management Inc. 120,000$433,0000.16%
TSP Capital Management Group, LLC 49,175$178,0000.10%
Spark Investment Management LLC 373,609$1,348,0000.09%
Connor, Clark & Lunn Investment Management Ltd. 3,191,964$11,523,0000.08%
View complete list of ASSERTIO THERAPEUTICS INC shareholders